
pm et
summari global medic devic manufactur oper segment cardiac vascular
minim invas therapi restor therapi diabet
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
dec pm stock trade
look apr sale grow
billion grow
includ juli divestitur
lower-margin medic suppli busi
estim includ impact busi
divestitur organ basi grew
expect see organ growth
growth driven
new product emerg market
signific presenc emerg
market china latin america
appear promis emerg
market grew currency-adjust
basi due broad base sale strength
emerg market account
revenu vs
quarter achiev
million synergi commit relat
acquisit covidien
quarter announc enterpris
excel initi deliv billion
annual gross run rate save
margin basi point
meanwhil expect oper
margin
find share trade
forward ep estim
attract valu encourag
pipelin invest high
growth area larg matur compani
wide breadth depth product
servic offer think
product alon substanti impact
result rather success multipl
product requir outperform
expect favor view
pipelin includ promis
recent launch product
intelli implant
neurostimul nov expect
launch long-anticip robot assist
surgeri platform like
risk opinion target includ loss
share key market slowdown emerg
market addit delay robot
program weaker-than-expect free cash
target price
forward pe rang
risk assess reflect exposur intens
competit area medic equip market
typic character short product life cycl
price pressur threat new market entrant
howev think potenti neg off-set
mani competit advantag scale
oper sale forc product breadth
ep estim base cfra oper earn histor
earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
senior vice presid
global oper
corpor overview lead manufactur develop market medic
devic therapi compani report total net sale fiscal year apr billion
broken follow oper segment cardiac vascular group billion
minim invas technolog group billion restor therapi group billion
cardiac vascular group compris cardiac rhythm heart failur crhf diseas
manag divis coronari structur heart divis aortic peripher vascular
divis chrf divis develop manufactur market product diagnosi treatment
manag heart rhythm disord heart failur princip product servic offer
implant cardiac resynchron therapi devic atrial fibril ablat product
coronari structur heart divis includ therapi treat coronari arteri diseas heart valv
disord product coronari stent replac heart valv aortic
peripher vascular divis compris comprehens line product therapi treat aortic
diseas includ product endovascular stent graft system peripher drug coat
minim invas therapi group consist surgic innov divis
market advanc gener surgic product includ surgic stapl devic vessel seal
instrument wound closur electrosurgeri product hernia mechan devic mesh implant well
gynecolog product therapi treat diseas condit typic exclus
address surgeon respiratori gastrointestin renal divis develop manufactur
market product emerg field minim invas gastrointestin diagnost therapi
respiratori monitor airway manag ventil therapi treatment renal
restor therapi group made spine brain specialti therapi pain therapi
divis spine divis develop manufactur market comprehens line medic devic
implant use treatment spine musculoskelet system includ biolog solut
orthoped dental market brain therapi divis develop manufactur market
integr portfolio devic therapi treatment neurolog disord diseas
well surgic technolog design improv precis workflow neuro procedur
specialti therapi divis develop manufactur market product therapi treat diseas
ear nose throat ent help control system overact bladder non-obstruct urinari
retent chronic fecal incontin pain therapi divis develop manufactur market
spinal cord stimul system implant drug infus system chronic pain well
diabet group develop manufactur market product servic manag
type type ii diabet princip product servic offer group includ insulin pump
minim system continu glucos monitor system therapi manag
softwar help patient healthcar provid manag diabet treatment
competit landscap compet therapeut diagnost medic market
countri throughout world substanti exposur market us
fy revenu came non-u develop market came emerg market
one largest medic devic compani domin presenc mani
medic devic market high switch cost custom recent
environ manag care econom motiv custom consolid among health care
provid increas competit declin reimburs rate increasingli requir
compet basi price
impact major develop mdt last major acquisit covidien plc januari
billion januari quarter achiev million synergi commit relat
acquisit quarter announc enterpris excel initi deliv billion
annual gross run rate save subsequ five year
financi trend revenu grew year-over-year billion fy april
compar five-year cumul annual growth rate compound-annual-growth-rate adjust earn per share grew
year-over-year fy per share compar five-year compound-annual-growth-rate april
net debt total capit ratio cash flow oper billion
fy year-end lower billion billion achiev fy fy respect
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc novemb technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
posit continu expect
compani sub-industri grow
posit macro environ addit
sub-industri mani product area
histor recession-resist
particularli equip use non-elect
procedur valuat continu high
industri driven expand margin
robust revenu growth compani
industri think lax food
drug administr fda
increas capabl technolog
enabl medic devic manufactur bring
innov product market faster
constant currenc basi expect
revenu sub-industri rise
high-single-digit low-double-digit
percentag driven continu pipelin
innov new product emerg market
expans speed new product
come market increas recent
year success effort
fda reduc approv time medic
devic time see price
pressur incess head wind medic
impact trade war appear mild
far medic equip compani
accord medic devic trade
septemb retaliatori tariff
billion us medic technolog export
although us chines govern
seek lower health care cost provid
equip manufactur insul
industri earlier commentari
medic devic manufactur suggest
impact trade war would manag
provid commentari impact
trade war earn
on-going threat state health
care system current us
administr continu attempt repeal
afford act stop
multipl time gather suffici
number vote pass variou repeal
replac bill recent on-going
lawsuit texa question
constitution
think import watch
mid-term elect novemb
health care appear import topic
hospit spend larg driver medic
equip sale robust
strong us economi
tax cut job act tcja individu
mandat roll think
hospit could see pressur lead
sale pressur medic equip
requir american health
insur without requir
expect lower number american
gener see posit long-term
fundament includ increas global
demand qualiti health care age
popul rise outlay lead
steadi flow innov product
 health equip
sub-index increas vs rise
 composit index year
date septemb
increas composit
base index
five-year market price perform dec
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
keep target line peer
forward ep estim jan-q ep vs
view lower-than-expect margin oper margin fell bp
yet encourag broad-bas growth cardiac vascular sale
rose aid new evolut transcathet aortic valv tav see
tav market among fastest grow encourag uptak
evolut minim invas sale rose pro forma restor therapi
diabet group rose /jeffrey loo cfa
et cfra keep buy opinion share plc
keep target in-lin peer
forward ep estim oct-q ep vs
view lower fy april fy ep estim
sale account divestitur fell
rose pro-forma basi sale driven robust sale emerg
market account sale sale broad-bas
note diabet sale limit sensor suppli constraint said
capac expans remain on-track /jeffrey loo cfa
et cfra keep buy opinion share plc
keep target in-lin peer fy
apr ep estim jul-q ep vs ahead
estim sale rose sale emerg market
account sale sale neg impact
vascular group sale rose minim invas therapi restor
therapi diabet group fell see rebound diabet amid
strong adopt cgm sensor /jeffrey loo cfa
analyst research note compani news
et cfra reiter buy opinion share plc
rais target
ep multipl exce five-year rang
encourag pipelin newer product
invest higher growth area oct-q ep vs
higher estim rais juli ep
lower ep oct-q sale increas
organ basi revenu grew year-over-year emerg market grew
non-u develop market grew market grew
emerg market growth broad china grew eastern europ
middl east africa diabet group grew constant currenc
sale propel sustain global demand sensor-aug
insulin pump system also announc plan launch
long-anticip robot assist surgeri platform think
et cfra add share plc total return
model portfolio cfra favor view
pipelin includ promis recent product launch
sensor-aug insulin pump system intelli implant
neurostimul also expect posit updat develop surgic
robot howev cautiou given past delay robot program
commit invest increment billion research
 develop next decad find share trade
ep estim attract valu
target price ep estim
slightli peer higher five-year forward price-to-earnings rang
promis growth opportun pay annual
dividend think boost dividend
juli payment share yield replac abbvi inc
total return model portfolio christoph muir
rais target below-p
ep estim multipl exce mdt
rang encourag mdt
pipelin newer product invest higher growth area july-q ep
vs lower estim lower juli
ep report july-q sale decreas billion
includ impact divestitur mdt busi
organ basi revenu grew year-over-year
emerg market grew develop market grew growth
diabet group particularli strong july-q reflect
robust demand minim insulin pump also encourag
above-market high-teen world-wide growth mdt transcathet
aortic valv replac therapi driven continu adopt
evolut soon market japan /kevin huang cfa
maintain target below-p
apr ep estim multipl exce mdt
five-year forward pe rang encourag
growth opportun newer product mdt pipelin apr-q ep
vs line estim lower ep
initi ep apr-q sale increas
billion divestitur organ growth driven
diabet group coronari structur heart csh divis
impress constant currenc revenu growth achiev
diabet group strong global demand mdt
growth constant currenc apr-q driven
low-twenti constant currenc growth transcathet aortic valv
strength mdt evolut /kevin huang cfa
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
